ChemAI logo — THE FUTURE OF CHEMISTRY, POWERED BY AI

ChemAI

THE FUTURE OF CHEMISTRY, POWERED BY AI

Founded 2015 United Kingdom Leeds, United Kingdom 20 employees Post Ipo Equity Analytics, Biotechnology +1

General Information

Company Name ChemAI
Founded Year 2015
Location United Kingdom Leeds, United Kingdom +4
Employees 20
Industries Analytics, Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when ChemAI moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ChemAI

ChemAI, established in 2015, is revolutionizing the field of chemistry by utilizing advanced AI and machine learning technologies. Operating from their headquarters in the United Kingdom, ChemAI focuses on improving reproducibility and predictability in chemical research.

Their flagship product, SmartChemistry®, allows chemists to design and conduct experiments on an unparalleled scale. By integrating a robust knowledge base with reaction and real-time sensor data, the platform enhances laboratory experimentation, making it appealing to industries such as Analytics, Biotechnology, and Pharmaceuticals.

The company's innovation caught the attention of investors, including o2h Ventures, leading to their last recorded fundraising event through Post-IPO Equity on 18 March 2019. ChemAI, with its compelling value proposition embodied by its slogan, "THE FUTURE OF CHEMISTRY, POWERED BY AI," positions itself as a trailblazer ready to redefine traditional chemistry paradigms.

Taxonomy: AI in Chemistry, Reproducibility in Chemistry, Predictive Chemistry, SmartChemistry, DigitalGlassware, Synthesis Optimization, Pharmaceutical Research, Chemistry Experimentation, Fine Chemicals, Scientific Publishing, Laboratory Automation, Chemputer, Advanced Materials

Services & Products

AI-driven Chemistry Solutions
Reaction Optimization
Route Prediction Tools
Autonomous Manufacturing Development

Target Customers

Global Industry Leaders Chemical Manufacturers Research and Development Organizations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1
Investor
18 Mar 2019

ChemAI Alternatives & Competitors

View All Alternatives
ChemAI vs
Apex Molecular Ltd
Apex Molecular Ltd United Kingdom

Providing specialist chemistry synthesis services to the Life Science industry

Debt Financing
20 employees
Biotechnology, Health Care
ChemAI vs
1200 Pharma
1200 Pharma United States

We leverage our breakthrough chemistry, cutting edge computation & data-rich models to accelerate dr...

Series Unknown
32 employees
Biotechnology, Health Care
ChemAI vs

Predicting Chemistry

Grant
6 employees
AI, Biotechnology

FAQ About ChemAI

THE FUTURE OF CHEMISTRY, POWERED BY AI
ChemAI was founded in 2015.
ChemAI is headquartered in Leeds, United Kingdom.
ChemAI operates in the following industries: Analytics, Biotechnology, Pharmaceutical.
ChemAI has approximately 20 employees.
ChemAI has completed 1 funding round. The latest funding stage is Post Ipo Equity.
ChemAI offers: AI-driven Chemistry Solutions, Reaction Optimization, Route Prediction Tools, Autonomous Manufacturing Development.
Top alternatives and competitors to ChemAI include Apex Molecular Ltd, 1200 Pharma, Hafnium Labs, German Chemical Society (GDCh), Bellen Chemistry Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ChemAI and Apex Molecular Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ChemAI and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy